Excelestar Ventures
About Excelestar Ventures
Excelestar Ventures is a venture capital firm that invests in early and late-stage companies across various sectors and geographies. The firm focuses on providing capital to businesses seeking to expand their operations and achieve sustainable growth. Excelestar Ventures has a diverse portfolio that includes investments in healthcare, technology, clean energy, and real estate sectors. The firm is committed to supporting companies with innovative solutions and strong growth potential. The firm's investment strategy involves conducting extensive market research and consultations with industry experts to identify undervalued companies with proven intrinsic value. Excelestar Ventures is selective in its investments, aiming to yield solid returns for its investors. The firm has a global presence, understanding that opportunities for success are not limited by borders but made possible through efficient and robust business models. Excelestar Ventures has a track record of investing in companies such as Adona Medical, Brixton Biosciences, Instylla, Sealonix, Datacy, Concerto Biosciences, Chromatic 3D Materials, RoadSync, and Brixton Biosciences. The firm is led by Founding Partner Tasneem Dohadwala, who has a background in financial services and has served on the boards of various companies. Excelestar Ventures is headquartered in Andover, Massachusetts, United States, and operates globally, with investments in countries including the United States, India, United Kingdom, China, Germany, France, Canada, Australia, Japan, South Korea, Brazil, Mexico, South Africa, Russia, Italy, Spain, Netherlands, Sweden, Switzerland, and Belgium.
Investment Mandate
Investment Stages2
Asset Classes2
Geographical Focus
African markets1
Other stated markets19
Requirements
Innovative solutions, Strong growth potential, Operational efficiency, Sustainable profits, Proven intrinsic value
Stated Portfolio8
As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.
Is this you?
Claim this investor profile to manage your firm's information.
Claim this profileReport an error